Drug policies have traditionally sought to suppress supply and deter use through the application of punitive laws. Today, there is a growing recognition that these drug policies have not only failed to reach their objectives but have resulted in a great deal of collateral damage. Drug policy must be reformed to focus on health, human rights and development objectives, with the aim of making the market less harmful rather than necessarily reducing its size.
The Count the Costs campaign calls upon world leaders and UN agencies to quantify the unintended negative consequences of the current approach to drugs, and assess the potential costs and benefits of alternative approaches to drug policy.
The TNI-EMCDDA Expert Seminar on Threshold Quantities reflected on the advantages and disadvantages of threshold quantities as a policy and legislative tool and it was hoped that this seminar would provide a springboard to inform current debate and to assist the elaboration of evidence-based drug…
This briefing provides an overview of the current discussion around threshold quantities and explores the mechanism of threshold quantities including their benefits and drawbacks as a policy and legal tool.
This briefing paper provides an overview of issues related to kratom legislation and policy in Thailand as well as a set of conclusions and recommendations to contribute to a reassessment of the current ban on kratom in Thailand and the region.
This report aims to provide the reader with a summary of what happened at 54th Session of the Commission on Narcotic Drugs, including at various satellite events, and offers some analysis of the key discussions and debates.